z-logo
open-access-imgOpen Access
A Deep Intronic HADH Splicing Mutation (c.636+471G>T) in a Congenital Hyperinsulinemic Hypoglycemia Case: Long Term Clinical Course
Author(s) -
Emine Çamtosun,
Sarah E. Flanagan,
Sian Ellard,
Zeynep Şıklar,
Khalid Hussain,
Pınar Kocaay,
Merih Berberoğlu
Publication year - 2015
Publication title -
journal of clinical research in pediatric endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.566
H-Index - 35
eISSN - 1308-5735
pISSN - 1308-5727
DOI - 10.4274/jcrpe.1963
Subject(s) - medicine , hyperinsulinemic hypoglycemia , hypoglycemia , hyperinsulinism , mutation , congenital hyperinsulinism , hyperinsulinemia , endocrinology , pediatrics , rna splicing , genetics , gene , insulin , insulin resistance , biology , rna
Unlike other congenital fatty acid oxidation defects, short-chain L-3-hydroxyacyl-CoA (SCHAD, HADH) deficiency is characterised by hypoglycemia with hyperinsulinism in the neonatal or infancy periods. The long-term and detailed clinical progression of the disease is largely unknown with almost 40 patients reported and only a few patients described clinically. We present clinical and laboratory findings together with the long-term clinical course of a case with a deep intronic HADH splicing mutation (c.636+471G>T) causing neonatal-onset hyperinsulinemic hypoglycemia with mild progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom